Al Hammadi Holding Co. announced on December 3, 2025, the signing of a share subscription agreement to acquire 40% of Wareed Medical Company for SAR 113 million. The investment will be paid in installments, with an initial payment of SAR 20 million and the remainder over five years based on performance metrics. Wareed operates 60 branches providing medical laboratory and home healthcare services across Saudi Arabia, with revenues growing from SAR 1,203,394 in 2022 to SAR 38,773,926 in 2024. The acquisition, financed through Al Hammadi's internal resources, aims to expand its healthcare ecosystem and diversify income sources.

Original announcement:

Important Notice: The announcement information and market data in this report are sourced directly from the Saudi Exchange (Tadawul). This summary is generated by Sahm’s proprietary AI model for informational purposes only. While we strive for accuracy, it should not be construed as financial advice or an investment recommendation.